BridgeMD
New treatment option for Parkinson Disease
Official title Application of Thoracic Epidural SCS for Managing FOG in Patients With Advanced Parkinson's Disease
ClinicalTrials.gov ID: NCT06630702
What this study is testing
- What it's testing
- Spinal cord stimulation (SCS) has proven to be effective for pain that is unresponsive to medication. This technique involves an anesthesiologist or a neurosurgeon placing stimulation electrodes at the thoracic vertebrae to provide pain relief.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 85
You may be able to join if
- Age:40-85 years old.
- Patients with primary Parkinson\'s disease who have been diagnosed by a movement disorder specialist for more than 5 years. Although they have a...
- No other secondary gait problems.
You likely can't join if
- Atypical Parkinson's disease.
- Patients with spinal cord injuries.
- Medication-controlled frozen gait.
- It is expected that there are lesions near the implantation area causing spinal canal stenosis or myelopathy (can be ruled out by MRI).
- It is expected that the implantation area has undergone previous surgery or there is infection near the implantation area, which may affect the...
- People with abnormal coagulation function (such as hemophilia patients) or those who have been controlled by long-term use of antithrombotic drugs...
See the full eligibility criteria
- Age:40-85 years old.
- Patients with primary Parkinson\'s disease who have been diagnosed by a movement disorder specialist for more than 5 years. Although they have a clear response to drugs, they have a frozen gait that cannot be controlled...
- No other secondary gait problems.
- Atypical Parkinson's disease.
- Patients with spinal cord injuries.
- Medication-controlled frozen gait.
- It is expected that there are lesions near the implantation area causing spinal canal stenosis or myelopathy (can be ruled out by MRI).
- It is expected that the implantation area has undergone previous surgery or there is infection near the implantation area, which may affect the success rate of implantation or increase concerns about complications (such...
- People with abnormal coagulation function (such as hemophilia patients) or those who have been controlled by long-term use of antithrombotic drugs and cannot stop taking them in a short period of time.
- CDR (Clinical Dementia Rating Scale) ≧2. 8. Those who are allergic to developer.
The study team makes the final eligibility decision.
Where it's taking place
- Hsinchu, Hsinchu City, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hsinchu, Hsinchu City, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.